Related Experiment Video
Updated: Jun 17, 2025

Orthopedic Robot-Assisted Femoral Neck System in the Treatment of Femoral Neck Fracture
Published on: March 3, 2023
Cannulated Screws or Hemiarthroplasty for Femoral Neck Fractures: Is There a Mortality Difference?
Austen L Thompson1, Nicolas P Kuttner, Marc Greenberg
1Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.
Objectives:
To determine the difference in mortality and reoperation rate between femoral neck fractures (FNFx) treated with cannulated screw (CS) fixation or hemiarthroplasty (HA).
Design:
Retrospective study.
Setting:
Institutional registry data from a single Level I trauma center.
Patient Selection Criteria:
Inclusion criteria were patients older than 60 years with FNFx (OTA/AO 31-B) who underwent primary operative treatment with a HA or CS.
Outcome Measures And Comparisons:
Mortality and reoperation rates following primary operative treatment between patients treated with either HA or CS. Kaplan-Meier survival curves were generated. Comparisons in the primary outcomes were made between the HA and CS cohorts using univariate and multivariate analyses where appropriate.
Results:
A total of 2211 patients were included in the study (1721 HA and 490 CS) and followed for an average of 34.5 months. The average age was 82.3 years (60-106 years), and patients were predominantly female (66.3%). One-year mortality was higher for the HA group compared with the CS group with a hazard ratio of 1.37 ( P = 0.03); however, over the lifetime of a patient or to the final follow-up, survival was not statistically significant (Relative Risk 0.95, 95% confidence interval, 0.83-1.1, P = 0.97). The rate of reoperation at 1 year was lower for HA (5.0%) than for CS (10.1%) (hazard ratio 3.0, 95% confidence interval, 2.1-4.34, P < 0.0001).
Conclusions:
Patients with FNFx treated with HA had the same risk of mortality as those treated with CS across the lifetime of patients or until the final follow-up. There is no difference in mortality at the 30-day and 90-day time point, but there is a significant difference in mortality at 1 year. HA treatment was associated with a significantly lower reoperation risk when compared with CS across the lifetime of the patient or until the final follow-up.
Level Of Evidence:
Therapeutic, Level III. See Instructions for Authors for a complete description of levels of evidence.
More Related Videos
06:41A Minimally Invasive Model to Analyze Endochondral Fracture Healing in Mice Under Standardized Biomechanical Conditions
Published on: March 22, 2018
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024